First Majestic Silver (NYSE:AG) (TSE:FR) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $11.00 price target on the stock. According to Zacks, “First Majestic Silver Corp. is engaged in the production, development, exploration, and acquisition of silver mines in Mexico. First Majestic Silver Corp. is headquartered in Vancouver, Canada. “
Great Ajax (NYSE:AJX) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Great Ajax Corp. is a real estate investment trust which acquires, invests and manages a portfolio of mortgage loans secured by single- family residences and single-family properties. The company invest in loans secured by multi-family residential and commercial mixed use retail/residential properties. It also hold real-estate owned properties acquired upon the foreclosure, other settlement of our owned non-performing loans. Great Ajax Corp. is based in Beaverton, Oregon. “
Asanko Gold (NYSEAMERICAN:AKG) (TSE:AKG) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Asanko Gold Inc. is a gold producer with its flagship asset, the Asanko Gold Mine, located in Ghana, West Africa. Asanko Gold Inc., formerly known as Keegan Resources Inc., is based in Vancouver, Canada. “
Akzo Nobel (OTCMKTS:AKZOY) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “AkzoNobel is a leading global paints and coatings company and a major producer of specialty chemicals. Their portfolio includes brands such as Dulux, Sikkens, International, Interpon and Eka. “
Alimera Sciences (NASDAQ:ALIM) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Alimera Sciences, Inc., based in Alpharetta, Georgia, is a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. The Company is presently focused on diseases affecting the back of the eye, or retina because it believes these diseases are not well treated with current therapies and represent a significant market opportunity. Its product candidate Iluvien(R) is an intravitreal insert containing fluocinolone acetonide, a non-proprietary corticosteroid with demonstrated efficacy in the treatment of ocular disease. Iluvien is in development for the treatment of diabetic macular edema (DME). DME is a disease of the retina that affects individuals with diabetes and can lead to severe vision loss and blindness. “
ANTA Sports Products (OTCMKTS:ANPDF) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “ANTA Sports Products Limited designs, develops, manufactures, trades, distributes, and markets sportswear in the People’s Republic of China. The company’s products include footwear, apparel, and accessories for professionals and the general public. ANTA Sports Products Limited is headquartered in Jinjiang City, the People’s Republic of China. “
Alpha and Omega Semiconductor (NASDAQ:AOSL) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $14.00 price target on the stock. According to Zacks, “Alpha and Omega Semiconductor Limited is engaged in designing, developing and supplying a broad range of power semiconductors globally, including a portfolio of Power MOSFET and Power IC products. The Company seeks to differentiate itself by integrating its expertise in device physics, process technology, design and advanced packaging to optimize product performance and cost. Its portfolio of products targets high-volume end-market applications, such as notebooks, netbooks, flat panel displays, mobile phone battery packs, set-top boxes, portable media players and power supplies. The products are incorporated into devices by original equipment manufacturers, or OEMs. The Company utilizes third-party foundries for all of its wafer fabrication and it deploys and implements its proprietary MOSFET processes at these third party foundries. The Company relies upon its in-house capacity and an associated provider for most of its packaging and testing requirements. “
Aptinyx (NASDAQ:APTX) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Aptinyx Inc. is a bio-pharmaceutical company. It focuses on discovery, development, and commercialization of novel, proprietary and synthetic small molecules for the treatment of brain and nervous system disorders. The company’s product pipeline consists of NYX-2925, NYX-783 and NYX-458 which are in clinical stage. Aptinyx Inc. is based in IL, United States. “
ASSD BRIT FOODS/ADR (OTCMKTS:ASBFY) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $35.00 target price on the stock. According to Zacks, “Associated British Foods is a diversified international food, ingredients and retail group. The group is one of Europe’s largest food companies with a wide range of successful brands and products in the food sector, and an increasingly strong presence in advanced research and technology. “
Dropbox (NASDAQ:DBX) had its price target increased by Nomura from $25.00 to $27.00. Nomura currently has a buy rating on the stock.
Franklin Covey (NYSE:FC) had its target price increased by Barrington Research from $40.00 to $45.00.
Orthopediatrics (NASDAQ:KIDS) had its overweight rating reaffirmed by analysts at Piper Jaffray Companies. The firm currently has a $44.00 price target on the stock, up from their previous price target of $40.00.
PC Tel (NASDAQ:PCTI) had its price target raised by Lake Street Capital from $6.00 to $8.00. They currently have a buy rating on the stock.
Ritchie Bros. Auctioneers (NYSE:RBA) (TSE:RBA) was downgraded by analysts at National Bank Financial from a sector perform rating to an underperform rating.
Synaptics (NASDAQ:SYNA) had its target price raised by BMO Capital Markets to $50.00.
Receive News & Ratings for First Majestic Silver Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Majestic Silver Corp and related companies with MarketBeat.com's FREE daily email newsletter.